Global Peptide Therapeutics Sales Market Report 2018

ペプチド治療の世界市場:販売動向2018

◆タイトル:Global Peptide Therapeutics Sales Market Report 2018
◆商品コード:QYR80710082
◆調査・発行会社:QYResearch
◆発行日:2018年10月
◆ページ数:118
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、世界主要国(日本、アメリカ、中国、ヨーロッパ等)
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥436,000見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD8,000 ⇒換算¥872,000見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

本調査レポートでは、ペプチド治療の世界市場について調査・分析し、ペプチド治療のメーカー別販売量、市場シェア分析、種類別販売分析(注射、経口、その他)、用途別販売分析(がん、代謝異常、中枢神経系、その他)、地域別販売分析(米国、中国、欧州、日本、東南アジア、インド)、価格動向、企業動向、ペプチド治療産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。

・ペプチド治療市場概要
・ペプチド治療のメーカー別販売量・メーカー別シェア
・ペプチド治療の世界市場:種類別販売量(注射、経口、その他)
・ペプチド治療の世界市場:用途別販売量(がん、代謝異常、中枢神経系、その他)
・ペプチド治療の世界市場:地域別販売量・市場シェア
・ペプチド治療の米国市場規模
・ペプチド治療の中国市場規模
・ペプチド治療の欧州市場規模
・ペプチド治療の日本市場規模
・ペプチド治療の東南アジア市場規模
・ペプチド治療のインド市場規模
・ペプチド治療のメーカー別分析(企業概要、事業概要、製品概要、収益、価格等)
・ペプチド治療のコスト分析・価格動向
・ペプチド治療の産業チェーン(サプライチェーン分析)
・ペプチド治療のマーケティング戦略・販売チャネル、流通業者
・ペプチド治療市場への影響要因分析
・ペプチド治療の世界市場予測
・ペプチド治療の米国市場予測
・ペプチド治療の中国市場予測
・ペプチド治療の欧州市場予測
・ペプチド治療の日本市場予測
・ペプチド治療の東南アジア市場予測
・ペプチド治療のインド市場予測
・ペプチド治療の種類別世界市場予測(注射、経口、その他)
・ペプチド治療の用途別世界市場予測(がん、代謝異常、中枢神経系、その他)
...

This report studies the global Peptide Therapeutics market status and forecast, categorizes the global Peptide Therapeutics market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).
Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another. Peptides are distinguished from proteins on the basis of size, and as a benchmark can be understood to contain approximately 50 amino acids or less.

In this report, we study the peptide-based drugs.
In the last several years, global market of Peptide Therapeutics developed rapidly, with an average growth rate of 7.7%. The major factors that are driving the growth of this market are the rising prevalence of metabolic disorders and the increasing pool of cancer patients. The technological advancements, resulting in a significant reduction in the production cost of peptide drugs, is also boosting this market remarkably. In 2017, global revenue of Peptide Therapeutics is nearly 28.5 billion USD; the actual production is about 150 million units.
The classification of Peptide Therapeutics includes Injection, Oral and other, and the proportion of Injection in 2017 is about 74.2%, and the proportion is decreasing trend from 2013 to 2018.
Peptide Therapeutics is widely sales for Cancer, Metabolic Disorders, Central Nervous System and Others. The key application of peptide therapeutics is into cancer mainly used for treating prostrate, pancreatic, ovarian, and breast cancer. and the consumption proportion is about 33.6% in 2017.
The global Peptide Therapeutics market is valued at 28500 million US$ in 2017 and will reach 37400 million US$ by the end of 2025, growing at a CAGR of 3.5% during 2018-2025.

The major players covered in this report
Sanofi
Teva
Novo Nordisk
Takeda
Eli Lilly
AstraZeneca
Novartis
Shire
AbbVie
Ipsen
Allergan
Ferring
Merck
The Medicines
Roche
J & J

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
United States
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Injection
Oral
Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Cancer
Metabolic Disorders
Central Nervous System
Other

The study objectives of this report are:
To analyze and study the global Peptide Therapeutics sales, value, status (2013-2017) and forecast (2018-2025);
To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
Focuses on the key Peptide Therapeutics players, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Peptide Therapeutics are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Peptide Therapeutics Manufacturers
Peptide Therapeutics Distributors/Traders/Wholesalers
Peptide Therapeutics Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company’s specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Peptide Therapeutics market, by end-use.
Detailed analysis and profiles of additional market players.

【レポートの目次】

Table of Contents

Global Peptide Therapeutics Sales Market Report 2018
1 Peptide Therapeutics Market Overview
1.1 Product Overview and Scope of Peptide Therapeutics
1.2 Classification of Peptide Therapeutics by Product Category
1.2.1 Global Peptide Therapeutics Market Size (Sales) Comparison by Type (2013-2025)
1.2.2 Global Peptide Therapeutics Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 Injection
1.2.4 Oral
1.2.5 Other
1.3 Global Peptide Therapeutics Market by Application/End Users
1.3.1 Global Peptide Therapeutics Sales (Volume) and Market Share Comparison by Application (2013-2025)
1.3.1 Cancer
1.3.2 Metabolic Disorders
1.3.3 Central Nervous System
1.3.4 Other
1.4 Global Peptide Therapeutics Market by Region
1.4.1 Global Peptide Therapeutics Market Size (Value) Comparison by Region (2013-2025)
1.4.2 United States Peptide Therapeutics Status and Prospect (2013-2025)
1.4.3 Europe Peptide Therapeutics Status and Prospect (2013-2025)
1.4.4 China Peptide Therapeutics Status and Prospect (2013-2025)
1.4.5 Japan Peptide Therapeutics Status and Prospect (2013-2025)
1.4.6 Southeast Asia Peptide Therapeutics Status and Prospect (2013-2025)
1.4.7 India Peptide Therapeutics Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Peptide Therapeutics (2013-2025)
1.5.1 Global Peptide Therapeutics Sales and Growth Rate (2013-2025)
1.5.2 Global Peptide Therapeutics Revenue and Growth Rate (2013-2025)

2 Global Peptide Therapeutics Competition by Players/Suppliers, Type and Application
2.1 Global Peptide Therapeutics Market Competition by Players/Suppliers
2.1.1 Global Peptide Therapeutics Sales and Market Share of Key Players/Suppliers (2013-2018)
2.1.2 Global Peptide Therapeutics Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Peptide Therapeutics (Volume and Value) by Type
2.2.1 Global Peptide Therapeutics Sales and Market Share by Type (2013-2018)
2.2.2 Global Peptide Therapeutics Revenue and Market Share by Type (2013-2018)
2.3 Global Peptide Therapeutics (Volume and Value) by Region
2.3.1 Global Peptide Therapeutics Sales and Market Share by Region (2013-2018)
2.3.2 Global Peptide Therapeutics Revenue and Market Share by Region (2013-2018)
2.4 Global Peptide Therapeutics (Volume) by Application

3 United States Peptide Therapeutics (Volume, Value and Sales Price)
3.1 United States Peptide Therapeutics Sales and Value (2013-2018)
3.1.1 United States Peptide Therapeutics Sales and Growth Rate (2013-2018)
3.1.2 United States Peptide Therapeutics Revenue and Growth Rate (2013-2018)
3.1.3 United States Peptide Therapeutics Sales Price Trend (2013-2018)
3.2 United States Peptide Therapeutics Sales Volume and Market Share by Players (2013-2018)
3.3 United States Peptide Therapeutics Sales Volume and Market Share by Type (2013-2018)
3.4 United States Peptide Therapeutics Sales Volume and Market Share by Application (2013-2018)

4 Europe Peptide Therapeutics (Volume, Value and Sales Price)
4.1 Europe Peptide Therapeutics Sales and Value (2013-2018)
4.1.1 Europe Peptide Therapeutics Sales and Growth Rate (2013-2018)
4.1.2 Europe Peptide Therapeutics Revenue and Growth Rate (2013-2018)
4.1.3 Europe Peptide Therapeutics Sales Price Trend (2013-2018)
4.2 Europe Peptide Therapeutics Sales Volume and Market Share by Players (2013-2018)
4.3 Europe Peptide Therapeutics Sales Volume and Market Share by Type (2013-2018)
4.4 Europe Peptide Therapeutics Sales Volume and Market Share by Application (2013-2018)

5 China Peptide Therapeutics (Volume, Value and Sales Price)
5.1 China Peptide Therapeutics Sales and Value (2013-2018)
5.1.1 China Peptide Therapeutics Sales and Growth Rate (2013-2018)
5.1.2 China Peptide Therapeutics Revenue and Growth Rate (2013-2018)
5.1.3 China Peptide Therapeutics Sales Price Trend (2013-2018)
5.2 China Peptide Therapeutics Sales Volume and Market Share by Players (2013-2018)
5.3 China Peptide Therapeutics Sales Volume and Market Share by Type (2013-2018)
5.4 China Peptide Therapeutics Sales Volume and Market Share by Application (2013-2018)

6 Japan Peptide Therapeutics (Volume, Value and Sales Price)
6.1 Japan Peptide Therapeutics Sales and Value (2013-2018)
6.1.1 Japan Peptide Therapeutics Sales and Growth Rate (2013-2018)
6.1.2 Japan Peptide Therapeutics Revenue and Growth Rate (2013-2018)
6.1.3 Japan Peptide Therapeutics Sales Price Trend (2013-2018)
6.2 Japan Peptide Therapeutics Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Peptide Therapeutics Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Peptide Therapeutics Sales Volume and Market Share by Application (2013-2018)

7 Southeast Asia Peptide Therapeutics (Volume, Value and Sales Price)
7.1 Southeast Asia Peptide Therapeutics Sales and Value (2013-2018)
7.1.1 Southeast Asia Peptide Therapeutics Sales and Growth Rate (2013-2018)
7.1.2 Southeast Asia Peptide Therapeutics Revenue and Growth Rate (2013-2018)
7.1.3 Southeast Asia Peptide Therapeutics Sales Price Trend (2013-2018)
7.2 Southeast Asia Peptide Therapeutics Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Peptide Therapeutics Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Peptide Therapeutics Sales Volume and Market Share by Application (2013-2018)

8 India Peptide Therapeutics (Volume, Value and Sales Price)
8.1 India Peptide Therapeutics Sales and Value (2013-2018)
8.1.1 India Peptide Therapeutics Sales and Growth Rate (2013-2018)
8.1.2 India Peptide Therapeutics Revenue and Growth Rate (2013-2018)
8.1.3 India Peptide Therapeutics Sales Price Trend (2013-2018)
8.2 India Peptide Therapeutics Sales Volume and Market Share by Players (2013-2018)
8.3 India Peptide Therapeutics Sales Volume and Market Share by Type (2013-2018)
8.4 India Peptide Therapeutics Sales Volume and Market Share by Application (2013-2018)

9 Global Peptide Therapeutics Players/Suppliers Profiles and Sales Data
9.1 Sanofi
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Peptide Therapeutics Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Sanofi Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
9.1.4 Main Business/Business Overview
9.2 Teva
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Peptide Therapeutics Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Teva Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
9.2.4 Main Business/Business Overview
9.3 Novo Nordisk
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Peptide Therapeutics Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Novo Nordisk Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
9.3.4 Main Business/Business Overview
9.4 Takeda
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Peptide Therapeutics Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Takeda Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
9.4.4 Main Business/Business Overview
9.5 Eli Lilly
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Peptide Therapeutics Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Eli Lilly Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
9.5.4 Main Business/Business Overview
9.6 AstraZeneca
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Peptide Therapeutics Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 AstraZeneca Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
9.6.4 Main Business/Business Overview
9.7 Novartis
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Peptide Therapeutics Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Novartis Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
9.7.4 Main Business/Business Overview
9.8 Shire
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Peptide Therapeutics Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Shire Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
9.8.4 Main Business/Business Overview
9.9 AbbVie
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Peptide Therapeutics Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 AbbVie Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
9.9.4 Main Business/Business Overview
9.10 Ipsen
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Peptide Therapeutics Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Ipsen Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
9.10.4 Main Business/Business Overview
9.11 Allergan
9.12 Ferring
9.13 Merck
9.14 The Medicines
9.15 Roche
9.16 J & J

10 Peptide Therapeutics Maufacturing Cost Analysis
10.1 Peptide Therapeutics Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Peptide Therapeutics
10.3 Manufacturing Process Analysis of Peptide Therapeutics

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Peptide Therapeutics Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Peptide Therapeutics Major Manufacturers in 2017
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Peptide Therapeutics Market Forecast (2018-2025)
14.1 Global Peptide Therapeutics Sales Volume, Revenue and Price Forecast (2018-2025)
14.1.1 Global Peptide Therapeutics Sales Volume and Growth Rate Forecast (2018-2025)
14.1.2 Global Peptide Therapeutics Revenue and Growth Rate Forecast (2018-2025)
14.1.3 Global Peptide Therapeutics Price and Trend Forecast (2018-2025)
14.2 Global Peptide Therapeutics Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
14.2.1 Global Peptide Therapeutics Sales Volume and Growth Rate Forecast by Regions (2018-2025)
14.2.2 Global Peptide Therapeutics Revenue and Growth Rate Forecast by Regions (2018-2025)
14.2.3 United States Peptide Therapeutics Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.4 Europe Peptide Therapeutics Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.5 China Peptide Therapeutics Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.6 Japan Peptide Therapeutics Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.7 Southeast Asia Peptide Therapeutics Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.8 India Peptide Therapeutics Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Peptide Therapeutics Sales Volume, Revenue and Price Forecast by Type (2018-2025)
14.3.1 Global Peptide Therapeutics Sales Forecast by Type (2018-2025)
14.3.2 Global Peptide Therapeutics Revenue Forecast by Type (2018-2025)
14.3.3 Global Peptide Therapeutics Price Forecast by Type (2018-2025)
14.4 Global Peptide Therapeutics Sales Volume Forecast by Application (2018-2025)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Peptide Therapeutics
Figure Global Peptide Therapeutics Sales Volume Comparison (K Units) by Type (2013-2025)
Figure Global Peptide Therapeutics Sales Volume Market Share by Type (Product Category) in 2017
Figure Injection Product Picture
Figure Oral Product Picture
Figure Other Product Picture
Figure Global Peptide Therapeutics Sales Comparison (K Units) by Application (2013-2025)
Figure Global Sales Market Share of Peptide Therapeutics by Application in 2017
Figure Cancer Examples
Table Key Downstream Customer in Cancer
Figure Metabolic Disorders Examples
Table Key Downstream Customer in Metabolic Disorders
Figure Central Nervous System Examples
Table Key Downstream Customer in Central Nervous System
Figure Other Examples
Table Key Downstream Customer in Other
Figure Global Peptide Therapeutics Market Size (Million USD) by Regions (2013-2025)
Figure United States Peptide Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Peptide Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Peptide Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Peptide Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Peptide Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Peptide Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Peptide Therapeutics Sales Volume (K Units) and Growth Rate (2013-2025)
Figure Global Peptide Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Market Major Players Peptide Therapeutics Sales Volume (K Units) (2013-2018)
Table Global Peptide Therapeutics Sales (K Units) of Key Players/Suppliers (2013-2018)
Table Global Peptide Therapeutics Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Peptide Therapeutics Sales Share by Players/Suppliers
Figure 2017 Peptide Therapeutics Sales Share by Players/Suppliers
Figure Global Peptide Therapeutics Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Peptide Therapeutics Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Peptide Therapeutics Revenue Share by Players/Suppliers (2013-2018)
Table 2017 Global Peptide Therapeutics Revenue Share by Players
Table 2017 Global Peptide Therapeutics Revenue Share by Players
Table Global Peptide Therapeutics Sales (K Units) and Market Share by Type (2013-2018)
Table Global Peptide Therapeutics Sales Share (K Units) by Type (2013-2018)
Figure Sales Market Share of Peptide Therapeutics by Type (2013-2018)
Figure Global Peptide Therapeutics Sales Growth Rate by Type (2013-2018)
Table Global Peptide Therapeutics Revenue (Million USD) and Market Share by Type (2013-2018)
Table Global Peptide Therapeutics Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Peptide Therapeutics by Type (2013-2018)
Figure Global Peptide Therapeutics Revenue Growth Rate by Type (2013-2018)
Table Global Peptide Therapeutics Sales Volume (K Units) and Market Share by Region (2013-2018)
Table Global Peptide Therapeutics Sales Share by Region (2013-2018)
Figure Sales Market Share of Peptide Therapeutics by Region (2013-2018)
Figure Global Peptide Therapeutics Sales Growth Rate by Region in 2017
Table Global Peptide Therapeutics Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Peptide Therapeutics Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Peptide Therapeutics by Region (2013-2018)
Figure Global Peptide Therapeutics Revenue Growth Rate by Region in 2017
Table Global Peptide Therapeutics Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Peptide Therapeutics Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Peptide Therapeutics by Region (2013-2018)
Figure Global Peptide Therapeutics Revenue Market Share by Region in 2017
Table Global Peptide Therapeutics Sales Volume (K Units) and Market Share by Application (2013-2018)
Table Global Peptide Therapeutics Sales Share (%) by Application (2013-2018)
Figure Sales Market Share of Peptide Therapeutics by Application (2013-2018)
Figure Global Peptide Therapeutics Sales Market Share by Application (2013-2018)
Figure United States Peptide Therapeutics Sales (K Units) and Growth Rate (2013-2018)
Figure United States Peptide Therapeutics Revenue (Million USD) and Growth Rate (2013-2018)
Figure United States Peptide Therapeutics Sales Price (USD/Unit) Trend (2013-2018)
Table United States Peptide Therapeutics Sales Volume (K Units) by Players (2013-2018)
Table United States Peptide Therapeutics Sales Volume Market Share by Players (2013-2018)
Figure United States Peptide Therapeutics Sales Volume Market Share by Players in 2017
Table United States Peptide Therapeutics Sales Volume (K Units) by Type (2013-2018)
Table United States Peptide Therapeutics Sales Volume Market Share by Type (2013-2018)
Figure United States Peptide Therapeutics Sales Volume Market Share by Type in 2017
Table United States Peptide Therapeutics Sales Volume (K Units) by Application (2013-2018)
Table United States Peptide Therapeutics Sales Volume Market Share by Application (2013-2018)
Figure United States Peptide Therapeutics Sales Volume Market Share by Application in 2017
Figure Europe Peptide Therapeutics Sales (K Units) and Growth Rate (2013-2018)
Figure Europe Peptide Therapeutics Revenue (Million USD) and Growth Rate (2013-2018)
Figure Europe Peptide Therapeutics Sales Price (USD/Unit) Trend (2013-2018)
Table Europe Peptide Therapeutics Sales Volume (K Units) by Players (2013-2018)
Table Europe Peptide Therapeutics Sales Volume Market Share by Players (2013-2018)
Figure Europe Peptide Therapeutics Sales Volume Market Share by Players in 2017
Table Europe Peptide Therapeutics Sales Volume (K Units) by Type (2013-2018)
Table Europe Peptide Therapeutics Sales Volume Market Share by Type (2013-2018)
Figure Europe Peptide Therapeutics Sales Volume Market Share by Type in 2017
Table Europe Peptide Therapeutics Sales Volume (K Units) by Application (2013-2018)
Table Europe Peptide Therapeutics Sales Volume Market Share by Application (2013-2018)
Figure Europe Peptide Therapeutics Sales Volume Market Share by Application in 2017
Figure China Peptide Therapeutics Sales (K Units) and Growth Rate (2013-2018)
Figure China Peptide Therapeutics Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Peptide Therapeutics Sales Price (USD/Unit) Trend (2013-2018)
Table China Peptide Therapeutics Sales Volume (K Units) by Players (2013-2018)
Table China Peptide Therapeutics Sales Volume Market Share by Players (2013-2018)
Figure China Peptide Therapeutics Sales Volume Market Share by Players in 2017
Table China Peptide Therapeutics Sales Volume (K Units) by Type (2013-2018)
Table China Peptide Therapeutics Sales Volume Market Share by Type (2013-2018)
Figure China Peptide Therapeutics Sales Volume Market Share by Type in 2017
Table China Peptide Therapeutics Sales Volume (K Units) by Application (2013-2018)
Table China Peptide Therapeutics Sales Volume Market Share by Application (2013-2018)
Figure China Peptide Therapeutics Sales Volume Market Share by Application in 2017
Figure Japan Peptide Therapeutics Sales (K Units) and Growth Rate (2013-2018)
Figure Japan Peptide Therapeutics Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Peptide Therapeutics Sales Price (USD/Unit) Trend (2013-2018)
Table Japan Peptide Therapeutics Sales Volume (K Units) by Players (2013-2018)
Table Japan Peptide Therapeutics Sales Volume Market Share by Players (2013-2018)
Figure Japan Peptide Therapeutics Sales Volume Market Share by Players in 2017
Table Japan Peptide Therapeutics Sales Volume (K Units) by Type (2013-2018)
Table Japan Peptide Therapeutics Sales Volume Market Share by Type (2013-2018)
Figure Japan Peptide Therapeutics Sales Volume Market Share by Type in 2017
Table Japan Peptide Therapeutics Sales Volume (K Units) by Application (2013-2018)
Table Japan Peptide Therapeutics Sales Volume Market Share by Application (2013-2018)
Figure Japan Peptide Therapeutics Sales Volume Market Share by Application in 2017
Figure Southeast Asia Peptide Therapeutics Sales (K Units) and Growth Rate (2013-2018)
Figure Southeast Asia Peptide Therapeutics Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Peptide Therapeutics Sales Price (USD/Unit) Trend (2013-2018)
Table Southeast Asia Peptide Therapeutics Sales Volume (K Units) by Players (2013-2018)
Table Southeast Asia Peptide Therapeutics Sales Volume Market Share by Players (2013-2018)
Figure Southeast Asia Peptide Therapeutics Sales Volume Market Share by Players in 2017
Table Southeast Asia Peptide Therapeutics Sales Volume (K Units) by Type (2013-2018)
Table Southeast Asia Peptide Therapeutics Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Peptide Therapeutics Sales Volume Market Share by Type in 2017
Table Southeast Asia Peptide Therapeutics Sales Volume (K Units) by Application (2013-2018)
Table Southeast Asia Peptide Therapeutics Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Peptide Therapeutics Sales Volume Market Share by Application in 2017
Figure India Peptide Therapeutics Sales (K Units) and Growth Rate (2013-2018)
Figure India Peptide Therapeutics Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Peptide Therapeutics Sales Price (USD/Unit) Trend (2013-2018)
Table India Peptide Therapeutics Sales Volume (K Units) by Players (2013-2018)
Table India Peptide Therapeutics Sales Volume Market Share by Players (2013-2018)
Figure India Peptide Therapeutics Sales Volume Market Share by Players in 2017
Table India Peptide Therapeutics Sales Volume (K Units) by Type (2013-2018)
Table India Peptide Therapeutics Sales Volume Market Share by Type (2013-2018)
Figure India Peptide Therapeutics Sales Volume Market Share by Type in 2017
Table India Peptide Therapeutics Sales Volume (K Units) by Application (2013-2018)
Table India Peptide Therapeutics Sales Volume Market Share by Application (2013-2018)
Figure India Peptide Therapeutics Sales Volume Market Share by Application in 2017
Table Sanofi Basic Information List
Table Sanofi Peptide Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Sanofi Peptide Therapeutics Sales Growth Rate (2013-2018)
Figure Sanofi Peptide Therapeutics Sales Global Market Share (2013-2018)
Figure Sanofi Peptide Therapeutics Revenue Global Market Share (2013-2018)
Table Teva Basic Information List
Table Teva Peptide Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Teva Peptide Therapeutics Sales Growth Rate (2013-2018)
Figure Teva Peptide Therapeutics Sales Global Market Share (2013-2018)
Figure Teva Peptide Therapeutics Revenue Global Market Share (2013-2018)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Peptide Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novo Nordisk Peptide Therapeutics Sales Growth Rate (2013-2018)
Figure Novo Nordisk Peptide Therapeutics Sales Global Market Share (2013-2018
Figure Novo Nordisk Peptide Therapeutics Revenue Global Market Share (2013-2018)
Table Takeda Basic Information List
Table Takeda Peptide Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Takeda Peptide Therapeutics Sales Growth Rate (2013-2018)
Figure Takeda Peptide Therapeutics Sales Global Market Share (2013-2018)
Figure Takeda Peptide Therapeutics Revenue Global Market Share (2013-2018)
Table Eli Lilly Basic Information List
Table Eli Lilly Peptide Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Eli Lilly Peptide Therapeutics Sales Growth Rate (2013-2018)
Figure Eli Lilly Peptide Therapeutics Sales Global Market Share (2013-2018)
Figure Eli Lilly Peptide Therapeutics Revenue Global Market Share (2013-2018)
Table AstraZeneca Basic Information List
Table AstraZeneca Peptide Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure AstraZeneca Peptide Therapeutics Sales Growth Rate (2013-2018)
Figure AstraZeneca Peptide Therapeutics Sales Global Market Share (2013-2018
Figure AstraZeneca Peptide Therapeutics Revenue Global Market Share (2013-2018)
Table Novartis Basic Information List
Table Novartis Peptide Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novartis Peptide Therapeutics Sales Growth Rate (2013-2018)
Figure Novartis Peptide Therapeutics Sales Global Market Share (2013-2018)
Figure Novartis Peptide Therapeutics Revenue Global Market Share (2013-2018)
Table Shire Basic Information List
Table Shire Peptide Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Shire Peptide Therapeutics Sales Growth Rate (2013-2018)
Figure Shire Peptide Therapeutics Sales Global Market Share (2013-2018
Figure Shire Peptide Therapeutics Revenue Global Market Share (2013-2018)
Table AbbVie Basic Information List
Table AbbVie Peptide Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure AbbVie Peptide Therapeutics Sales Growth Rate (2013-2018)
Figure AbbVie Peptide Therapeutics Sales Global Market Share (2013-2018)
Figure AbbVie Peptide Therapeutics Revenue Global Market Share (2013-2018)
Table Ipsen Basic Information List
Table Ipsen Peptide Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Ipsen Peptide Therapeutics Sales Growth Rate (2013-2018)
Figure Ipsen Peptide Therapeutics Sales Global Market Share (2013-2018)
Figure Ipsen Peptide Therapeutics Revenue Global Market Share (2013-2018)
Table Allergan Basic Information List
Table Ferring Basic Information List
Table Merck Basic Information List
Table The Medicines Basic Information List
Table Roche Basic Information List
Table J & J Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Peptide Therapeutics
Figure Manufacturing Process Analysis of Peptide Therapeutics
Figure Peptide Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of Peptide Therapeutics Major Players in 2017
Table Major Buyers of Peptide Therapeutics
Table Distributors/Traders List
Figure Global Peptide Therapeutics Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Global Peptide Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Peptide Therapeutics Price (USD/Unit) and Trend Forecast (2018-2025)
Table Global Peptide Therapeutics Sales Volume (K Units) Forecast by Regions (2018-2025)
Figure Global Peptide Therapeutics Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Peptide Therapeutics Sales Volume Market Share Forecast by Regions in 2025
Table Global Peptide Therapeutics Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Peptide Therapeutics Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Peptide Therapeutics Revenue Market Share Forecast by Regions in 2025
Figure United States Peptide Therapeutics Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Peptide Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Europe Peptide Therapeutics Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Europe Peptide Therapeutics Revenue and Growth Rate Forecast (2018-2025)
Figure China Peptide Therapeutics Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure China Peptide Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Peptide Therapeutics Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Japan Peptide Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Peptide Therapeutics Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Peptide Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Peptide Therapeutics Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure India Peptide Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Peptide Therapeutics Sales (K Units) Forecast by Type (2018-2025)
Figure Global Peptide Therapeutics Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Peptide Therapeutics Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Peptide Therapeutics Revenue Market Share Forecast by Type (2018-2025)
Table Global Peptide Therapeutics Price (USD/Unit) Forecast by Type (2018-2025)
Table Global Peptide Therapeutics Sales (K Units) Forecast by Application (2018-2025)
Figure Global Peptide Therapeutics Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【レポートのキーワード】

ペプチド治療、注射、経口、がん、代謝異常、中枢神経系

【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[ペプチド治療の世界市場:販売動向2018] (Global Peptide Therapeutics Sales Market Report 2018 / QYR80710082)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆